Anders Kverneland

Medicin og biovidenskab

1. Tumor-Infiltrating Lymphocytes 100%
2. Cell- and Tissue-Based Therapy 56%
3. Melanoma 41%
4. Neoplasms 27%
5. Ipilimumab 25%
6. T-Lymphocytes 24%
7. Proteomics 23%
8. Ovarian Neoplasms 23%
9. Immune Reconstitution 16%
10. Ultracentrifugation 15%
11. Extracellular Vesicles 15%
12. Clustered Regularly Interspaced Short Palindromic Repeats 14%
13. Autoantigens 14%
14. Neoplasm Antigens 13%
15. Proteome 13%
16. Immunity 11%
17. Anti-Idiotypic Antibodies 10%
18. Prostatic Neoplasms 10%
19. Vaccines 9%
20. Workflow 9%
21. Bone Marrow 9%
22. Vemurafenib 9%
23. Drug Therapy 9%
24. Therapeutics 9%
25. Survival 9%
26. Immunotherapy 8%
27. In Vitro Techniques 8%
28. Blocking Antibodies 8%
29. B-Cell Lymphoma 6%
30. Biomarkers 5%
31. Pharmaceutical Preparations 5%
32. Tumor Microenvironment 5%